The legacy of Viagra, and its parent company copyright, presents a challenging case study for investors. Originally a blockbuster drug, producing billions in income, its intellectual property lapse created a flood of generic competition , significantly eroding its market share . While certain firms may attempt to capitalize on related treatments… Read More